E1	Procedure:T1 Name:T2 Temporality:E33
E3	Procedure:T3 Name:T4
E9	Condition:T9 Name:T10
E11	Procedure:T11 Name:T12
E12	Age:T25 Eq-Comparison:E13
E13	Eq-Comparison:T36 Operator:T13 Value:T26 Temporal-Unit:T27 Value2:T21 Operator2:T14
E15	Eq-Comparison:T38 Operator:T15 Value:T29
E16	Eq-Comparison:T39 Operator:T16 Value:T30
E17	Eq-Comparison:T40 Operator:T17 Value:T31 Unit:T59 Unit2:T60
E18	Eq-Comparison:T41 Operator:T18 Unit:T24 Value:T33
E19	Eq-Comparison:T42 Operator:T19 Value:T34 Temporal-Unit:T87
E20	Eq-Comparison:T43 Operator:T20 Value:T35 Temporal-Unit:T103
E21	Eq-Comparison:T44 Temporal-Period:T45
E22	Eq-Comparison:T46 Temporal-Period:T47
E2	Or:T48 Arg:T8 Arg2:T5
E4	Condition:T37 Name:T49 Duration:E7
E5	Modifier:T50 Modifies:T49
E7	Eq-Comparison:T51 Operator:T52 Value:T28 Temporal-Unit:T22
E6	Observation:T6 Name:T7
E8	Observation:T53 Name:T54 Eq-Comparison:E15
E10	Observation:T55 Name:T56 Eq-Comparison:E16
E14	Observation:T57 Name:T58 Eq-Comparison:E17
E23	Eq-Comparison:T62 Temporal-Period:T63
E24	Drug:T64 Name:T65 Temporality:E21 Temporality2:E23
E25	Condition:T67 Name:T68
E26	Assertion:T69 Asserted:E25
E27	Condition:T70 Name:T71
E28	Assertion:T72 Asserted:E27
E29	Or:T73 Arg:E27 Arg2:E3
E30	Study:T74
E31	Temporal-Connection:T75 Arg:E3 Arg2:E30
E32	Study:T76 Study-Of:E1
E33	Eq-Comparison:T77 Temporal-Recency:T78
E34	Temporal-Connection:T79 Arg:E35 Arg2:E33
E35	Eq-Comparison:T80 Value:T32 Temporal-Unit:T23
E36	And:T81 Arg:E30 Arg2:E35
E37	Observation:T82 Name:T83 Eq-Comparison:E18
E38	Condition:T84 Name:T85 Temporality:E19
E39	Modifier:T86 Modifies:T85
E40	Condition:T88 Name:T89
E41	Or:T90 Arg:E38 Arg2:E40
E42	Procedure:T91
E43	Modifier:T92 Modifies:T12
E44	Modifier:T93 Modifies:T12
E45	Or:T94 Arg:E44 Arg2:E43
E46	Assertion:T95 Asserted:E42
E47	Drug:T96 Name:T97
E48	Drug:T98 Name:T99
E49	Drug:T100 Name:T101 Temporality:E20
E50	Or:T102 Arg:E48 Arg2:E49
E51	Condition:T104 Name:T105 Temporality:E22
E52	Drug:T106 Name:T107
E53	Drug:T108 Name:T109
E54	Modifier:T110 Modifies:T109
E55	Modifier:T111 Modifies:T109
E56	Or:T112 Arg:E55 Arg2:E54
E57	Condition:T113 Severity:T114
T1	Procedure 564 549	drug injection
T2	Procedure-Name 564 549	drug injection
T3	Procedure 489 475	contraception
T4	Procedure-Name 489 475	contraception
T5	Life-Stage-And-Gender 42 42	female
T8	Life-Stage-And-Gender 32 32	Male
T9	Condition 848 824	anaphylaxis
T10	Condition-Name 848 824	anaphylaxis
T11	Procedure 729 710	antibiotics
T12	Procedure-Name 729 710	antibiotics
T13	Eq-Operator 53 53	≥
T15	Eq-Operator 195 190	≥
T16	Eq-Operator 217 210	≥
T17	Eq-Operator 243 234	≥
T18	Eq-Operator 609 592	<
T19	Eq-Operator 648 630	within
T20	Eq-Operator 783 761	within
T22	Eq-Temporal-Unit 142 139	years
T23	Eq-Temporal-Unit 528 513	weeks
T24	Eq-Unit 616 598	kg
T25	Age 79 77	age
T26	Eq-Value 57 56	12
T28	Eq-Value 136 133	2
T29	Eq-Value 199 193	16
T30	Eq-Value 220 212	3
T31	Eq-Value 247 237	10
T32	Eq-Value 522 507	12
T33	Eq-Value 613 595	30
T34	Eq-Value 651 632	1
T35	Eq-Value 786 763	1
T36	Eq-Comparison 72 70	≥ 12 to < 18 years
T38	Eq-Comparison 199 193	≥ 16
T39	Eq-Comparison 220 212	≥ 3
T40	Eq-Comparison 270 259	≥ 10% of Body Surface Area
T41	Eq-Comparison 616 598	< 30 kg
T42	Eq-Comparison 656 637	within 1 week
T43	Eq-Comparison 791 768	within 1 week
T44	Eq-Comparison 310 296	history
T45	Eq-Temporal-Period 310 296	history
T46	Eq-Comparison 804 781	History
T47	Eq-Temporal-Period 804 781	History
T48	Or 35 35	or
T14	Eq-Operator 60 59	to
T21	Eq-Value 66 64	18
T27	Eq-Temporal-Unit 72 70	years
T37	Condition 95 93	AD
T49	Condition-Name 95 93	AD
T50	Modifier 92 90	Chronic
T51	Eq-Comparison 142 139	at least 2 years
T52	Eq-Operator 133 131	at least
T6	Observation 178 175	Eczema Area and Severity Index
T7	Observation-Name 178 175	Eczema Area and Severity Index
T53	Observation 185 181	EASI
T54	Observation-Name 185 181	EASI
T55	Observation 209 202	IGA
T56	Observation-Name 209 202	IGA
T57	Observation 241 232	AD involvement
T58	Observation-Name 241 232	AD involvement
T59	Eq-Unit 249 238	%
T60	Eq-Unit 270 259	Body Surface Area
T61	Eq-Unit 276 264	BSA
T62	Eq-Comparison 302 288	recent
T63	Eq-Temporal-Period 302 288	recent
T64	Drug 356 342	topical medications
T65	Drug-Name 356 342	topical medications
T66	Life-Stage-And-Gender 367 353	Women
T67	Condition 383 369	childbearing
T68	Condition-Name 383 369	childbearing
T69	Assertion 393 379	potential
T70	Condition 429 415	abstinent
T71	Condition-Name 429 415	abstinent
T72	Assertion 407 393	agree to
T73	Or 432 418	or
T74	Study 510 496	study
T75	Temporal-Connection 500 486	throughout
T76	Study 549 534	study
T77	Eq-Comparison 543 528	last
T78	Eq-Temporal-Recency 543 528	last
T79	Temporal-Connection 534 519	after
T80	Eq-Comparison 528 513	12 weeks
T81	And 514 500	and
T82	Observation 607 590	Body weight
T83	Observation-Name 607 590	Body weight
T84	Condition 641 623	infection
T85	Condition-Name 641 623	infection
T86	Modifier 631 613	Cutaneous
T87	Eq-Temporal-Unit 656 637	week
T88	Condition 673 654	infection
T89	Condition-Name 673 654	infection
T90	Or 659 640	or
T91	Procedure 693 674	treatment
T92	Modifier 717 698	parenteral
T93	Modifier 703 684	oral
T94	Or 706 687	or
T95	Assertion 683 664	requiring
T96	Drug 742 722	antivirals
T97	Drug-Name 742 722	antivirals
T98	Drug 759 738	antiparasitics
T99	Drug-Name 759 738	antiparasitics
T100	Drug 776 754	antifungals
T101	Drug-Name 776 754	antifungals
T102	Or 764 742	or
T103	Eq-Temporal-Unit 791 768	week
T104	Condition 824 801	hypersensitivity
T105	Condition-Name 824 801	hypersensitivity
T106	Drug 879 854	immunoglobulin product
T107	Drug-Name 879 854	immunoglobulin product
T108	Drug 940 910	monoclonal antibody
T109	Drug-Name 940 910	monoclonal antibody
T110	Modifier 913 885	recombinant
T111	Modifier 898 870	plasma-derived
T112	Or 901 873	or
T113	Condition 981 949	issue
T114	Severity 975 943	significant
A1	Life-Stage-And-Gender-Type T5 female
A2	Life-Stage-And-Gender-Type T8 male
A3	Eq-Operator-Value T13 GTEQ
A5	Eq-Operator-Value T15 GTEQ
A6	Eq-Operator-Value T16 GTEQ
A7	Eq-Operator-Value T17 GTEQ
A8	Eq-Operator-Value T18 LT
A9	Eq-Operator-Value T19 LTEQ
A10	Eq-Operator-Value T20 LTEQ
A12	Eq-Temporal-Unit-Value T22 year
A13	Eq-Temporal-Unit-Value T23 week
A14	Eq-Temporal-Period-Value T45 past
A15	Eq-Temporal-Period-Value T47 past
A4	Eq-Operator-Value T14 BETWEEN
A11	Eq-Temporal-Unit-Value T27 year
A16	Eq-Operator-Value T52 GTEQ
A17	Observation-Type-Value T7 clinical-score
A18	Observation-Type-Value T56 clinical-score
A19	Observation-Type-Value T58 measurement
A20	Eq-Temporal-Period-Value T63 recent
A21	Life-Stage-And-Gender-Type T66 female
A22	Assertion-Type-Value E26 hypothetical
A23	Assertion-Type-Value E28 hypothetical
A24	Temporal-Connection-Type-Value E31 during
A25	Eq-Temporal-Recency-Value T78 most-recent-time
A26	Temporal-Connection-Type-Value E34 after
A27	Observation-Type-Value T83 vital
A28	Eq-Temporal-Unit-Value T87 week
A29	Assertion-Type-Value E46 hypothetical
A30	Eq-Temporal-Unit-Value T103 week
A31	Severity-Value T114 severe
R1	Abbrev-Of Arg1:E8 Arg2:E6
R2	Abbrev-Of Arg1:T61 Arg2:T60
R3	If-Then Arg1:T66 Arg2:E25
R4	If-Then Arg1:E25 Arg2:E27
R5	Using Arg1:E42 Arg2:E11
R6	Treatment-For Arg1:E42 Arg2:E40
R7	Example-Of Arg1:E9 Arg2:E51
R8	Caused-By Arg1:E51 Arg2:E52
R9	Example-Of Arg1:E53 Arg2:E52